Poland· PL-100504861
Winrevair
A antihypertensives for pulmonary arterial hypertension product containing sotaterceptum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sotaterceptum is registered in 3 of 19 countries.
Countries holding a registration under ATC C02KX (antihypertensives for pulmonary arterial hypertension), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Sotaterceptum · ATC C02KX
3 / 19 countries
- Canada
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Sotaterceptum
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- C02KX
- ATC class
- Antihypertensives for pulmonary arterial hypertension
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sotaterceptum in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandWinrevairMerck Sharp & Dohme B.V.*
- CzechiaWINREVAIRMerck Sharp & Dohme B.V., Haarlem
- SwedenWinrevair 45 mg Pulver och vätska till injektionsvätska, lösningMerck Sharp & Dohme BV
- BelgiumWinrevair 45 mgMerck Sharp & Dohme
- United KingdomWinrevair 45mg powder and solvent for solution for injection vialsMerck Sharp & Dohme (UK) Ltd
- SpainWINREVAIR 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEMerck Sharp & Dohme B.V.
- SwitzerlandWinrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungMSD Merck Sharp & Dohme AG
- FinlandWinrevairMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Winrevair
- Liechtenstein · Winrevair
- Norway · Winrevair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a9009e2-83b0-4b2d-971f-16632ac2b74b GET /v1/drugs/9a9009e2-83b0-4b2d-971f-16632ac2b74b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "45 mg",
"packaging": "Rpz ¦ EU/1/24/1850/006 ¦ 157887\n2 fiol. 45 mg\nRpz ¦ EU/1/24/1850/005 ¦ 157888\n1 fiol. 45 mg proszku",
"substance": "Sotaterceptum 45 mg",
"common_name": "Sotaterceptum",
"pl_product_id": "100504861",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sotaterceptum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.